The US Bankruptcy Court granted an order for relief for liquidation under Chapter 7 for the involuntary petition filed against Generex Biotechnology Corp. on June 6, 2022. The debtor listed its assets of $338.41 million and liabilities of $521.63 million.
Generex Biotechnology Corporation
Equities
GNBT
US3714853013
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |